Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.

Clinical rheumatology - 1 Dec 2003

Nakamura Tadashi, Yamamura Yuji, Tomoda Kunihiko, Tsukano Michishi, Shono Masahiro, Baba Satoshi

Abstract excerpt

Secondary amyloid A (AA) amyloidosis is an uncommon yet important complication of rheumatoid arthritis (RA). It is one of the most relentless of the extra-articular features of RA, and suitable treatments have not yet been found. We studied the efficacy of cyclophosphamide (CYC) combined with prednisolone (PSL) in amyloidotic patients who had serum amyloid A (SAA) 1.3 genotype, which is a risk factor for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis
Share to Apolipoproteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclophosphamide

Share to Drug Administration Schedule

Share to Prednisolone

Share to Probability

Share to Serum Amyloid A Protein

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 14677008
DOI: 10.1007/s10067-003-0763-9

Genes

CRP
SAA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.PMID 14677008Read ↗

Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis.Semantic proximity Read ↗

Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis.Semantic proximity Read ↗

SAA4 is a Diagnostic Marker to Enhance Detection Forrheumatoid Arthritis Combined with Anti-CCPSemantic proximity Read ↗

Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis.Semantic proximity Read ↗

Amyloid A amyloidosis in a patient with Caplan's syndrome, with special reference to genetic predisposition.Semantic proximity Read ↗

Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis.Semantic proximity Read ↗

Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.